Skip to main content
Log in

Significant Correlation Between Maternal Body Mass Index at Delivery and in the Second Trimester, and Second Trimester Circulating Total Cell-free DNA Levels

  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

Objectives

The use of cell-free fetal deoxyribonucleic acid (DNA) requires the knowledge of variables that may influence the levels of cell-free DNA, such as maternal body mass index (BMI).

Material and methods

In this study, using 406 maternal blood samples from the second trimester of pregnancy, cell-free fetal DNA specific for the SRY and DYS14 loci and glyceraldehyde-3-phosphate dehydrogenase sequence were quantified by real-time polymerase chain reaction.

Results

No significant correlation was seen between the levels of cell-free fetal DNA and maternal BMI, whereas total cell-free DNA was significantly associated with maternal BMI at 20 to 21 weeks of gestation (P = .034) and at the end of pregnancy (R2 regression: 0.016, P = .014).

Conclusion

Quantitative levels of cell-free fetal DNA are not affected by maternal BMI, whereas total DNA levels in the second trimester significantly correlate with maternal BMI at the moment of blood drawing and at delivery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lo YM. Fetal DNA in maternal plasma: biology and diagnostic applications. Clin Chem. 2000;46:1903–1906.

    Article  CAS  Google Scholar 

  2. Maron JL, Bianchi DW. Prenatal diagnosis using cell-free nucleic acids in maternal body fluids: a decade of progress. Am J Med Genet C Semin Med Genet. 2007;145:5–17.

    Article  Google Scholar 

  3. Dennis Lo YM, Chiu RW. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis. Clin Chem. 2008;54:461–466.

    Article  Google Scholar 

  4. Jorgez CJ, Dang DD, Wapner R, Farina A, Simpson JL, Bischoff FZ. Elevated levels of total (maternal and fetal) beta-globin DNA in maternal blood from first trimester pregnancies with trisomy 21. Hum Reprod. 2007;22:2267–2272.

    Article  CAS  Google Scholar 

  5. Farina A, Sekizawa A, Iwasaki M, Matsuoka R, Ichizuka K, Okai T. Total cell-free DNA (beta-globin gene) distribution in maternal plasma at the second trimester: a new prospective for preeclampsia screening. Prenat Diagn. 2004;24:722–726.

    Article  CAS  Google Scholar 

  6. Zhong XY, Laivuori H, Livingston JC, et al. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol. 2001;184: 414–419.

    Article  CAS  Google Scholar 

  7. Diesch CH, Holzgreve W, Hahn S, Zhong XY. Comparison of activin A and cell-free fetal DNA levels in maternal plasma from patients at high risk for preeclampsia. Prenat Diagn. 2006;26:1267–1270.

    Article  CAS  Google Scholar 

  8. Catalano PM. Increasing maternal obesity and weight gain during pregnancy: the obstetric problems of plentitude. Obstet Gynecol. 2007;110:743–744.

    Article  Google Scholar 

  9. DeVader SR, Neeley HL, Myles TD, Leet TL. Evaluation of gestational weight gain guidelines for women with normal prepregnancy body mass index. Obstet Gynecol. 2007;110: 745–751.

    Article  Google Scholar 

  10. Kiel DW, Dodson EA, Artal R, Boehmer TK, Leet TL. Gestational weight gain and pregnancy outcomes in obese women: how much is enough? Obstet Gynecol. 2007;110: 752–758.

    Article  Google Scholar 

  11. Cedergren MI. Optimal gestational weight gain for body mass index categories. Obstet Gynecol. 2007;110:759–764.

    Article  Google Scholar 

  12. de Graaf IM, Cuckle HS, Pajkrt E, Leschot NJ, Bleker OP, van Lith JM. Co-variables in first trimester maternal serum screening. Prenat Diagn. 2000;20:186–189.

    Article  Google Scholar 

  13. Spencer K, Bindra R, Nicolaides KH. Maternal weight correction of maternal serum PAPP-A and free beta-hCG MoM when screening for trisomy 21 in the first trimester of pregnancy. Prenat Diagn. 2003;23:851–855.

    Article  Google Scholar 

  14. Lapaire O, Volgmann T, Huang D, Hahn S, Holzgreve W, Xiao Zhong Y. Maternal smoking: effect on circulating cell-free fetal and total DNA levels in maternal plasma from the second trimester. Obstet Gynecol. 2007;110:1358–1363.

    Article  CAS  Google Scholar 

  15. Zimmermann B, El-Sheikhah A, Nicolaides K, Holzgreve W, Hahn S. Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma. Clin Chem. 2005;51: 1598–1604.

    Article  CAS  Google Scholar 

  16. Zhong XY, Holzgreve W, Hahn S. Risk free simultaneous prenatal identification of fetal rhesus D status and sex by multiplex real-time PCR using cell free fetal DNA in maternal plasma. Swiss Med Wkly. 2001;131:70–74.

    CAS  PubMed  Google Scholar 

  17. Lo YM, Tein MS, Lau TK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet. 1998;62: 768–775.

    Article  CAS  Google Scholar 

  18. Hahn S, Huppertz B, Holzgreve W. Fetal cells and cell free fetal nucleic acids in maternal blood: new tools to study abnormal placentation? Placenta. 2005;26:515–526.

    Article  CAS  Google Scholar 

  19. Bianchi DW. Circulating fetal DNA: its origin and diagnostic potential—a review. Placenta. 2004;25:S93–S101.

    Article  CAS  Google Scholar 

  20. Zhong XY, Holzgreve W, Gebhardt S, et al. Minimal alteration in the ratio of circulatory fetal DNA to fetal corticotropin-releasing hormone mRNA level in preeclampsia. Fetal Diagn Ther. 2006;21:246–249.

    Article  Google Scholar 

  21. Sorensen T, Larsen SO, Christiansen M. Weight adjustment of serum markers in early first-trimester prenatal screening for Down syndrome. Prenat Diagn. 2005;25:484–488.

    Article  Google Scholar 

  22. Robinson HE, O’Connell CM, Joseph KS, McLeod NL. Maternal outcomes in pregnancies complicated by obesity. Obstet Gynecol. 2005;106:1357–1364.

    Article  Google Scholar 

  23. Bhattacharya S, Campbell DM, Liston WA, Bhattacharya S. Effect of body mass index on pregnancy outcomes in nulliparous women delivering singleton babies. BMC Public Health. 2007;7:168.

    Article  Google Scholar 

  24. Wataganara T, Peter I, Messerlian GM, Borgatta L, Bianchi DW. Inverse correlation between maternal weight and second trimester circulating cell-free fetal DNA levels. Obstet Gynecol. 2004;104:545–550.

    Article  Google Scholar 

  25. Huppertz B, Frank HG, Kingdom JC, Reister F, Kaufmann P. Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta. Histochem Cell Biol. 1998;110:495–508.

    Article  CAS  Google Scholar 

  26. Wataganara T, Metzenbauer M, Peter I, Johnson KL, Bianchi DW. Placental volume, as measured by 3-dimensional sonography and levels of maternal plasma cell-free fetal DNA. Am J Obstet Gynecol. 2005;193:496–500.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wolfgang Holzgreve MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lapaire, O., Volgmann, T., Grill, S. et al. Significant Correlation Between Maternal Body Mass Index at Delivery and in the Second Trimester, and Second Trimester Circulating Total Cell-free DNA Levels. Reprod. Sci. 16, 274–279 (2009). https://doi.org/10.1177/1933719108327599

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719108327599

Key words

Navigation